Matches in SemOpenAlex for { <https://semopenalex.org/work/W1567662909> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W1567662909 endingPage "98" @default.
- W1567662909 startingPage "90" @default.
- W1567662909 abstract "Vorapaxar is a novel orally active thrombin receptor antagonist selective for the PAR-1 receptor. This open-label, single-center, fixed-sequence, 2-period, 2-treatment study assessed the pharmacokinetics and pharmacodynamics of single-dose digoxin in the presence/absence of multiple-dose vorapaxar. Eighteen healthy adult subjects received two treatments in a fixed sequence separated by ≥8-day washout: (A) digoxin 0.5 mg (Day 1); (B) vorapaxar 2.5 mg/day Days 1–6 and single-dose vorapaxar 40 mg administered with single-dose digoxin 0.5 mg Day 7. The geometric mean ratio (%; GMR) for the two treatments (digoxin alone and digoxin plus vorapaxar) and 90% confidence intervals (CIs) for and AUCtf and Cmax of digoxin were calculated. Pharmacodynamics of digoxin was assessed by measuring changes in electrocardiogram (ECG) parameters. The GMR (90% CIs) estimates for digoxin AUCtf and Cmax were 105% (91, 121) and 154% (130, 181), respectively. Except for differences in peak plasma concentrations, the pharmacokinetics of digoxin were similar between the two treatments. Coadministration of vorapaxar plus digoxin had no effect on digoxin Tmax or ECG parameters. The results of this study suggest that the coadministration of vorapaxar and digoxin is unlikely to cause a clinically significant drug–drug interaction." @default.
- W1567662909 created "2016-06-24" @default.
- W1567662909 creator A5005738281 @default.
- W1567662909 creator A5010188573 @default.
- W1567662909 creator A5015685796 @default.
- W1567662909 creator A5021709407 @default.
- W1567662909 creator A5062291677 @default.
- W1567662909 creator A5084346964 @default.
- W1567662909 creator A5090216662 @default.
- W1567662909 date "2013-01-01" @default.
- W1567662909 modified "2023-09-27" @default.
- W1567662909 title "The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of Digoxin" @default.
- W1567662909 cites W1964470226 @default.
- W1567662909 cites W1988477907 @default.
- W1567662909 cites W1990381860 @default.
- W1567662909 cites W2020693635 @default.
- W1567662909 cites W2025233096 @default.
- W1567662909 cites W2037703702 @default.
- W1567662909 cites W2091409293 @default.
- W1567662909 cites W2126310184 @default.
- W1567662909 cites W2134322421 @default.
- W1567662909 cites W2142021807 @default.
- W1567662909 cites W2154382954 @default.
- W1567662909 cites W2172147566 @default.
- W1567662909 doi "https://doi.org/10.1002/cpdd.11" @default.
- W1567662909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27121563" @default.
- W1567662909 hasPublicationYear "2013" @default.
- W1567662909 type Work @default.
- W1567662909 sameAs 1567662909 @default.
- W1567662909 citedByCount "4" @default.
- W1567662909 countsByYear W15676629092014 @default.
- W1567662909 countsByYear W15676629092015 @default.
- W1567662909 countsByYear W15676629092017 @default.
- W1567662909 crossrefType "journal-article" @default.
- W1567662909 hasAuthorship W1567662909A5005738281 @default.
- W1567662909 hasAuthorship W1567662909A5010188573 @default.
- W1567662909 hasAuthorship W1567662909A5015685796 @default.
- W1567662909 hasAuthorship W1567662909A5021709407 @default.
- W1567662909 hasAuthorship W1567662909A5062291677 @default.
- W1567662909 hasAuthorship W1567662909A5084346964 @default.
- W1567662909 hasAuthorship W1567662909A5090216662 @default.
- W1567662909 hasConcept C111113717 @default.
- W1567662909 hasConcept C112705442 @default.
- W1567662909 hasConcept C126322002 @default.
- W1567662909 hasConcept C22979827 @default.
- W1567662909 hasConcept C2777707475 @default.
- W1567662909 hasConcept C2778198053 @default.
- W1567662909 hasConcept C71924100 @default.
- W1567662909 hasConcept C98274493 @default.
- W1567662909 hasConceptScore W1567662909C111113717 @default.
- W1567662909 hasConceptScore W1567662909C112705442 @default.
- W1567662909 hasConceptScore W1567662909C126322002 @default.
- W1567662909 hasConceptScore W1567662909C22979827 @default.
- W1567662909 hasConceptScore W1567662909C2777707475 @default.
- W1567662909 hasConceptScore W1567662909C2778198053 @default.
- W1567662909 hasConceptScore W1567662909C71924100 @default.
- W1567662909 hasConceptScore W1567662909C98274493 @default.
- W1567662909 hasIssue "1" @default.
- W1567662909 hasLocation W15676629091 @default.
- W1567662909 hasLocation W15676629092 @default.
- W1567662909 hasOpenAccess W1567662909 @default.
- W1567662909 hasPrimaryLocation W15676629091 @default.
- W1567662909 hasRelatedWork W1971830765 @default.
- W1567662909 hasRelatedWork W1997101420 @default.
- W1567662909 hasRelatedWork W2158380752 @default.
- W1567662909 hasRelatedWork W2418409895 @default.
- W1567662909 hasRelatedWork W2477866235 @default.
- W1567662909 hasRelatedWork W2766550598 @default.
- W1567662909 hasRelatedWork W2897749673 @default.
- W1567662909 hasRelatedWork W3097307756 @default.
- W1567662909 hasRelatedWork W3205517375 @default.
- W1567662909 hasRelatedWork W3207379667 @default.
- W1567662909 hasVolume "2" @default.
- W1567662909 isParatext "false" @default.
- W1567662909 isRetracted "false" @default.
- W1567662909 magId "1567662909" @default.
- W1567662909 workType "article" @default.